TP040/#1418 Palbociclib plus letrozole combination after progression on second-line chemotherapy for women with ER/PR-positive high-grade serous or endometrioid ovarian, fallopian tube or peritoneal cancer (LACOG 1018
Fernanda Damian, Graziela Zibetti Dal Molin, Angelica Rodrigues, Aknar De Carvalho Calabrich, Gustavo Werutsky, Elias Abdo Filho, Mirela Foresti Jimenez, Taiane Rebelatto, Rafaela De Jesus and Andreia Cristina De Melo
DOI: dx.doi.org/10.1136/ijgc-2022-igcs.549